Recondo G - Search Results

1

Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer.

Blaquier JB, Ortiz-Cuaran S, Ricciuti B, Mezquita L, Cardona AF, Recondo G. Blaquier JB, et al. Among authors: recondo g. Clin Cancer Res. 2023 Sep 15;29(18):3579-3591. doi: 10.1158/1078-0432.CCR-22-1912. Clin Cancer Res. 2023. PMID: 37093192 Review.

2

Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.

Recondo G, Armand JP, Tellez-Bernal E, Domenge C, Belehradek M, De Vathaire F, Wibault P, Richard JM, Cvitkovic E. Recondo G, et al. Laryngoscope. 1991 May;101(5):494-501. doi: 10.1288/00005537-199105000-00009. Laryngoscope. 1991. PMID: 1709437

3

Perianal ulcer in disseminated histoplasmosis.

Recondo G, Sella A, Ro JY, Dexeus FH, Amato R, Kilbourn R. Recondo G, et al. South Med J. 1991 Jul;84(7):931-2. doi: 10.1097/00007611-199107000-00031. South Med J. 1991. PMID: 2068646

4

Flavonoids: a new class of anticancer agents? Preclinical and clinical data of flavone acetic acid.

Armand J, De Forni M, Recondo G, Cals L, Cvitkovic E, Munck J. Armand J, et al. Among authors: recondo g. Prog Clin Biol Res. 1988;280:235-41. Prog Clin Biol Res. 1988. PMID: 3051027 Review. No abstract available.

5

Salvage chemotherapy in recurrent head and neck cancer: the Institut Gustave Roussy experience.

Armand JP, Cvitkovic E, Recondo G, Wibault P, Schwaab G, Domenge C, Tellez-Bernal E, Gandia D, Luboinski B, Eschwege F, et al. Armand JP, et al. Among authors: recondo g. Am J Otolaryngol. 1993 Sep-Oct;14(5):301-6. doi: 10.1016/0196-0709(93)90087-n. Am J Otolaryngol. 1993. PMID: 8238757 No abstract available.

6

5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.

Logothetis CJ, Hossan E, Recondo G, Sella A, Ellerhorst J, Kilbourn R, Zukiwski A, Amato R. Logothetis CJ, et al. Among authors: recondo g. Anticancer Res. 1994 May-Jun;14(3B):1265-9. Anticancer Res. 1994. PMID: 8067694 Clinical Trial.

7

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients.

de Forni M, Chabot GG, Armand JP, Fontana X, Recondo G, Domenge C, Carde P, Barbu M, Gouyette A. de Forni M, et al. Among authors: recondo g. Eur J Cancer. 1993;29A(7):983-8. doi: 10.1016/s0959-8049(05)80206-0. Eur J Cancer. 1993. PMID: 8499153 Clinical Trial.

8

Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans.

Robert J, Armand JP, Huet S, Klink-Alakl M, Recondo G, Hurteloup P. Robert J, et al. Among authors: recondo g. J Clin Oncol. 1992 Jul;10(7):1183-90. doi: 10.1200/JCO.1992.10.7.1183. J Clin Oncol. 1992. PMID: 1607922 Clinical Trial.

9

Phase II study of mitozolomide (M & B 39,565) in head and neck cancer.

Herait P, Armand JP, Benahmed M, Domenge C, Fontana X, Recondo G, Cvitkovic E, Delgado FM. Herait P, et al. Among authors: recondo g. Med Oncol Tumor Pharmacother. 1989;6(4):267-9. doi: 10.1007/BF02985159. Med Oncol Tumor Pharmacother. 1989. PMID: 2615530

10

[Flavone acetic acid and LY 186641 interfere in various ways in Jaffé's reaction].

Bonnay M, Gouyette A, Chabot G, Recondo G, Armand JP. Bonnay M, et al. Among authors: recondo g. Bull Cancer. 1989;76(8):839-41. Bull Cancer. 1989. PMID: 2620109 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page